![]() |
|
|
Unité 352 Institut National de la Santé et de la
Recherche Médicale, Biochimie et Pharmacologie Institut National
des Sciences Appliquées-Lyon, 69621 Villeurbanne, France (G.N.), and
Division of Reproductive Biology, Department of Gynecology and
Obstetrics, Stanford University School of Medicine, Stanford,
California 94305 (C.S., M.C.)
In rat thymic lymphocytes, accumulation of phosphatidic acid (PA)
occurs at the same time as decrease in cAMP levels and activation of a
cAMP-specific phosphodiesterase (PDE) [type 4, EC 3.1.4.17 (PDE4)].
We investigated the nature of the PDE activated by PA and the mechanism
of activation by using recombinant cAMP-specific PDE4 isoforms derived
from three different genes (PDE4A, PDE4B, and
PDE4D). The "long" variants expressed from each gene
(PDE4A5, PDE4B1, and PDE4D3) were activated by PA, whereas the
"short" variants (PDE4A1, PDE4B2, PDE4D1, and PDE4D2) were not.
Phosphatidylserine was an activator that was as effective as PA,
whereas phosphatidylcholine was ineffective, indicating that activation
was restricted to anionic phospholipids. PA caused an increase in the
Vmax value of PDE4D3 without affecting the
Km value of the enzyme for the
cAMP substrate. PA also caused a change in the Mg2+
requirement for hydrolysis. Half-maximal stimulation of the PDE was
obtained with ~10 µg/ml PA. Although protein kinase A-mediated phosphorylation of PDE4D3 produces effects similar to those elicited by
PA, the mechanism of PA-induced activation was not found to involve a
phosphorylation. Instead, several observations suggest that PA may
directly interact with the enzyme. The stimulation of cAMP PDEs by PA
and other acidic phospholipids may be a mechanism by which growth
factors and hormones modulate the cAMP-dependent signal transduction
pathway during cell stimulation.
This article has been cited by other articles:
![]() |
K. Omori and J. Kotera Overview of PDEs and Their Regulation Circ. Res., February 16, 2007; 100(3): 309 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Conti, W. Richter, C. Mehats, G. Livera, J.-Y. Park, and C. Jin Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling J. Biol. Chem., February 14, 2003; 278(8): 5493 - 5496. [Full Text] [PDF] |
||||
![]() |
G. S. Baillie, E. Huston, G. Scotland, M. Hodgkin, I. Gall, A. H. Peden, C. MacKenzie, E. S. Houslay, R. Currie, T. R. Pettitt, et al. TAPAS-1, a Novel Microdomain within the Unique N-terminal Region of the PDE4A1 cAMP-specific Phosphodiesterase That Allows Rapid, Ca2+-triggered Membrane Association with Selectivity for Interaction with Phosphatidic Acid J. Biol. Chem., July 26, 2002; 277(31): 28298 - 28309. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Nakajima, H. Sonoda, T. Mizoguchi, J. Aoki, H. Arai, M. Nagahama, M. Tagaya, and K. Tani A Novel Phospholipase A1 with Sequence Homology to a Mammalian Sec23p-interacting Protein, p125 J. Biol. Chem., March 22, 2002; 277(13): 11329 - 11335. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Naro, C. Sette, E. Vicini, V. De Arcangelis, M. Grange, M. Conti, M. Lagarde, M. Molinaro, S. Adamo, and G. Némoz Involvement of Type 4 cAMP-Phosphodiesterase in the Myogenic Differentiation of L6 Cells Mol. Biol. Cell, December 1, 1999; 10(12): 4355 - 4367. [Abstract] [Full Text] |
||||
![]() |
S. Bechoua, M. Dubois, G. Némoz, M. Lagarde, and A.-F. Prigent Docosahexaenoic acid lowers phosphatidate level in human activated lymphocytes despite phospholipase D activation J. Lipid Res., April 1, 1998; 39(4): 873 - 883. [Abstract] [Full Text] |
||||
![]() |
M. Grange, C. Sette, M. Cuomo, M. Conti, M. Lagarde, A.-F. Prigent, and G. Nemoz The cAMP-specific Phosphodiesterase PDE4D3 Is Regulated by Phosphatidic Acid Binding. CONSEQUENCES FOR cAMP SIGNALING PATHWAY AND CHARACTERIZATION OF A PHOSPHATIDIC ACID BINDING SITE J. Biol. Chem., October 20, 2000; 275(43): 33379 - 33387. [Abstract] [Full Text] [PDF] |
||||